Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Fish and Richardson
Cantor Fitzgerald
Farmers Insurance
Federal Trade Commission

Generated: September 22, 2017

DrugPatentWatch Database Preview

Phenoxybenzamine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for phenoxybenzamine hydrochloride and what is the scope of phenoxybenzamine hydrochloride patent protection?

Phenoxybenzamine hydrochloride
is the generic ingredient in two branded drugs marketed by Concordia Pharms Inc, Par Pharm Inc, and West-ward Pharms Int, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for phenoxybenzamine hydrochloride. Five suppliers are listed for this compound.

Summary for Generic Name: phenoxybenzamine hydrochloride

Drug Master File Entries: see list4
Suppliers / Packagers: see list5
Bulk Api Vendors: see list49
Clinical Trials: see list2,282
Patent Applications: see list693
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:phenoxybenzamine hydrochloride at DailyMed

Pharmacology for Ingredient: phenoxybenzamine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Concordia Pharms Inc
phenoxybenzamine hydrochloride
CAPSULE;ORAL008708-001Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
phenoxybenzamine hydrochloride
CAPSULE;ORAL201050-001Jul 16, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Par Pharm Inc
phenoxybenzamine hydrochloride
CAPSULE;ORAL204522-001Jan 24, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Daiichi Sankyo
US Army
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus